key: cord-0843481-f9j4kah1 authors: Wang, Xinhang; Chen, Lulu; Huang, Jinbao; Pan, Jianguang; Huang, Mingxiang; Chen, Lizhou title: Comparison of the clinical characteristics of patients with novel coronavirus pneumonia between China and overseas date: 2021-06-03 journal: J Clin Lab Anal DOI: 10.1002/jcla.23811 sha: 21762c4985e38e93a3d23884898b985de09b7d0e doc_id: 843481 cord_uid: f9j4kah1 BACKGROUND: To explore the clinical manifestation, imaging examination, and serology of patients with novel coronavirus pneumonia (COVID‐19) between China and overseas. METHODS: Ninety patients with COVID‐19 who admitted to Fuzhou Pulmonary Hospital from January 23, 2020, to May 1, 2020, were included in this retrospective study. They were divided into domestic group and overseas group according to the origin regions. The clinical manifestations, imaging examination, serology, treatment, and prognosis between the two groups were compared and analyzed. RESULTS: The clinical manifestations of patients in the two groups mainly included fever (83.1% and 47.4%), cough (62% and 31.6%), expectoration (47.9% and 31.6%), anorexia (28.2% and 47.4%), fatigue (21.1% and 10.5%), and dyspnea (22.5% and 0%). The main laboratory characteristics in the two groups were decreased lymphocyte count, increased lactate dehydrogenase, decreased oxygenation index, decreased white blood cell count, increased erythrocyte sedimentation rate (ESR), and increased C‐reactive protein. The computed tomography (CT) examinations of chest showed bilateral and peripheral involvement, with multiple patch shadows and ground glass shadows. However, pleural effusions were rare. CONCLUSION: Fever, cough, and dyspnea are more common in domestic cases than overseas cases. However, patients with COVID‐19 from overseas may have the symptoms of loss of taste and smell that domestic cases do not have. and serology of patients with COVID-19 between China and overseas. The research protocol was reviewed and approved by the Medical Ethics Committee of Fuzhou Pulmonary Hospital. All patients signed the informed consent forms. A total of 90 patients with COVID-19 who admitted to Fuzhou Pulmonary Hospital from January 23, 2020, to May 1, 2020, were included in this retrospective study. There were 42 males and 48 females, with the average age of (46.95 ± 17) years old (ranging from 19 to 93 years old). They were divided into domestic group (71 patients) and overseas group (19 patients) according to the origin regions. The classification criteria were performed as the novel coronavirus pneumonia diagnosis and treatment plan developed by the office of the National Health and Health Committee (revised version 7). 4 Diagnostic criteria for mild cases: the clinical symptoms were mild, and the imaging examination showed no pneumonia. Diagnostic criteria for common cases: There were fever, respiratory tract, and imaging examination manifestations of pneumonia. Diagnostic criteria for severe cases: those who met one of the following criteria. (a) There was shortness of breath, with breathing rate of ≥30 times/min; (b) In resting state, blood oxygen saturation was ≤93%; (c) PaO 2 /FiO 2 was ≤300 mmHg (1 mmHg = 0.133 kPa); (d) Imaging examination of the lung showed that the lesions were significantly progressed up to >50% within 24-48 h. In areas with high altitude (over 1000 meters above sea level), PaO 2 /FiO 2 should be corrected according to the following formula: PaO 2 /FiO 2 × (Atmospheric pressure [mmHg]/760). Diagnostic criteria for critical cases: those who met one of the following criteria. (a) Respiratory failure occurred and mechanical ventilation was required; (b) Shock occurred; (c) other organ failure occurred and ICU monitoring and treatment were required. Throat swabs and sputum were collected. RT-PCR was performed to detect the nucleic acid with SARS-CoV-2 nucleic acid testing reagent kit (Sun Yat-sen University Da'an gene Co., Ltd.) according to the instructions. The clinical manifestations, laboratory tests, imaging examination, treatment methods, and outcomes were observed and recorded. SPSS19.0 statistical software is used for statistical analysis. Counting data are expressed as the number of cases or percentage and compared by chi-square test. Measurement data are expressed as mean ± standard deviation (SD) and compared by independent sample t test when conforming to the normal distribution. Measurement data are expressed as median (interquartile range) and compared by rank sum test when they do not fit the normal distribution. p < 0.05 is considered as the statistically significant differences. The clinical manifestations in the two groups were shown in Table 2 . In the domestic group, the main symptoms were fever, cough, expectoration, anorexia, dyspnea, fatigue, diarrhea, and chills. Other symptoms included chest tightness, dizziness, sore body, sore throat, stuffy nose, and runny nose. In the overseas group, the incidences of dyspnea, cough, fever, and total respiratory symptoms were less than those in the domestic group (p < 0.05). Moreover, patients in the overseas group had the symptoms of losses of taste and smell, while those in the domestic group did not have. The other main symptoms in the overseas group were the same as those in the control group. The main laboratory features in the domestic group and overseas group were decreased lymphocyte count (46.5% and 52.5%), increased lactate dehydrogenase (88.7% and 73.7%), decreased oxygenation index (15.5% and 5.3%), decreased white blood cell count (12.7% and 31.6%), increased erythrocyte sedimentation rate (ESR) (69.0% and 47.4%), and increased C-reactive protein (47.9% and 36.8%) ( Table 3) . Moreover, the chest computed tomography (CT) examinations in the two groups were mainly bilateral and peripheral involvement, with multiple ground glass shadow, patchy shadow, and consolidation shadow. However, pleural effusions were rare. As shown in Table 4 , the prognosis of the domestic group was not consistent with that of the overseas group. The time of turning negative was longer in the overseas group than that in the domestic group (p < 0.05). Moreover, the time of abatement of fever was also longer in the overseas group than that in the domestic group (p < 0.05). There was a significant correlation between antipyretic time and virus negative time ( Figure 1A ). There was a significant correlation between virus negative time and oxygenation ( Figure 1B) . Moreover, there was a significant correlation between antipyretic time and oxygenation ( Figure 1C) . There was also a significant correlation between lymphocyte count and oxygenation ( Figure 1D ). Coronaviruses are a large class of viruses widely existing in nature. The newly discovered 2019-nCoV is the seventh known coronavirus to infect human. 5 Risk factors, including neutrophil count, high-sensitivity C-reactive protein, creatine kinase, and blood urea nitrogen, can help to early screen critically ill patients with COVID-19 of poor prognosis. 9 Our results also show that the main laboratory features in the two groups include decreased lymphocyte count, decreased leukocyte count, decreased oxygenation, increased lactate dehydrogenase, increased erythrocyte sedimentation rate, and increased C-reactive protein. Those results are similar with the previous study. 8 tions are also similar with the previous studies. 10, 11 Our results show that the prognosis of patients in the domes- There are also some limitations in this study. This study is a retrospective single-center study with small sample size and lack of more detailed epidemiological information (such as treatment measures and prognosis). We will continue to follow up and expand the sample size and conduct multi-center studies for further verification. In conclusion, the clinical characteristics of domestic group and overseas group are similar, but the symptoms of dyspnea in domestic group are more than those in overseas group. However, the clinical manifestations of patients with COVID-19 are not characteristic, so it is necessary to be vigilant for patients with atypical epidemiological and clinical characteristics. At the time of admission to confirm the diagnosis and discharge from the hospital to judge the condition, the negative virus nucleic acid test of the throat swab sample is used as the criterion to cure, which also needs to be careful to avoid misdiagnosis and missed diagnosis. Furthermore, COVID-19 should be more quickly and accurately diagnosed. F I G U R E 1 Correlation between clinical symptoms, oxygenation, and prognosis in the two groups The datasets used and/or analyzed during the current study available from the corresponding author on reasonable request. https://orcid.org/0000-0002-9680-4059 COVID-19 (Novel Coronavirus 2019) -recent trends How Did Chinese government implement unconventional measures against COVID-19 pneumonia Clinical features and dynamics of viral load in imported and non-imported patients with COVID-19 Expert recommendations for the diagnosis and treatment of interstitial lung disease caused by novel coronavirus pneumonia Resistance and disinfection of coronavirus A new coronavirus associated with human respiratory disease in China Analysis of clinical features and outcomes of 161 patients with severe and critical COVID-19: a multicenter descriptive study Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan Laboratory abnormalities and risk factors associated with in-hospital death in patients with severe COVID-19 Clinical features of patients infected with 2019 novel coronavirus in Wuhan Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Clinical features of COVID-19 convalescent patients with re-positive nucleic acid detection A comparative study of the laboratory features of COVID-19 and other viral pneumonias in the recovery stage Comparison of the clinical characteristics of patients with novel coronavirus pneumonia between China and overseas